- Release Date: 18/12/23 09:02
- Summary: P2 trial shows significant improvements in Phelan-McDermid
- Price Sensitive: Yes
- Download Document 723.12KB
Ann: P2 trial shows significant improvements in Phelan-McDermid
- There are more pages in this discussion • 208 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.29 |
Change
0.640(3.43%) |
Mkt cap ! $2.430B | |||
| Open | High | Low | Value | Volume |
| $18.80 | $19.30 | $18.78 | $1.685M | 88.72K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 584 | $19.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.29 | 181 | 5 |
View Market Depth
| Last trade - 11.59am 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.25 |
Change
0.640 ( 3.18 %) |
||||
| Open | High | Low | Volume | ||
| $19.09 | $19.31 | $18.80 | 33386 | ||
| Last updated 12.18pm 29/04/2024 ? | |||||
| NEU (ASX) Chart |